African American race portends a poorer response to chronic hepatitis C treatment.

被引：0
|
作者：
Lim, KN [1 ]
Bruno, CJ [1 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
434
引用
收藏
页码：269A / 269A
页数：1
相关论文
共 50 条
  • [41] PREDICTION OF RESPONSE TO INTERFERON TREATMENT OF CHRONIC HEPATITIS-C
    DAVIS, GL
    JOURNAL OF HEPATOLOGY, 1994, 21 (01) : 1 - 3
  • [42] Treatment of chronic hepatitis C in a state correctional facility - Response
    Allen, S
    Spaulding, A
    Riche, JD
    ANNALS OF INTERNAL MEDICINE, 2004, 140 (02) : 151 - 151
  • [43] A pharmacokinetic (PK) evaluation of ribavirin in African American and Caucasian patients with chronic hepatitis C
    Jin, Runyan
    Howell, Charles
    Dowling, Thomas
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (09): : 1129 - 1129
  • [44] The Effect of Donor Race On Survival of Hepatitis C-Positive African American Liver Transplant Patients
    Pang, Phillip S.
    Kamal, Ahmad
    Glenn, Jeffrey
    GASTROENTEROLOGY, 2009, 136 (05) : A795 - A795
  • [45] End-stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection
    Aslinia, F. M.
    Wasan, S. K.
    Mindikoglu, A. L.
    Adeyemo, O. A.
    Philosophe, B.
    Drachenberg, C.
    Howell, C. D.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (05) : 371 - 376
  • [46] Treatment of chronic hepatitis B and chronic hepatitis C
    Terrault, NA
    REVIEWS IN MEDICAL VIROLOGY, 1996, 6 (04) : 215 - 228
  • [47] AUTOIMMUNE SYNDROMES WITH CHRONIC HEPATITIS C VIRUS INFECTION AND DIRECT-ACTING ANTIVIRAL TREATMENT.
    Mohammed, R. H. A.
    Attia, D. Hassan
    Abdelazeem, M.
    Taha, A. Elsayed
    Bahgat, D. Rasheed
    Elmakhzangy, H. Ibrahim I.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 918 - 918
  • [48] THE SYSTEMS PHARMACOLOGY MODEL OF HEPATITIS C PROGRESSION AND TREATMENT.
    Yakovleva, T.
    Demin, O., Jr.
    Demin, O.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S7 - S7
  • [49] Genotype 6a chronic hepatitis C: Preliminary report of interferon and ribavirin combination treatment.
    Wong, VW
    Chan, HL
    Tam, JS
    Tsang, O
    Chan, FK
    Hui, AY
    Sung, JJ
    Leung, NW
    HEPATOLOGY, 2002, 36 (04) : 588A - 588A
  • [50] Hepatitis C: Screening and treatment. Recommendations and medical references
    Dhumeaux, D
    Doffoel, M
    Bedossa, P
    Bigard, MA
    Bismuth, H
    Cacoub, P
    Carpentier, F
    Courouce, AM
    Durocher, A
    Galmiche, JP
    Goudeau, A
    Hillon, P
    Marcellin, P
    OuldAoudia, V
    Pham, BN
    Raguin, G
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1997, 21 (01): : 45 - 49
12345